NORGINE B.V. ENTERS INTO EXCLUSIVE LICENCE AND DISTRIBUTION AGREEMENTS FOR THE COMMERCIALISATION OF PLENVU® IN A NUMBER OF COUNTRIES IN LATIN AMERICA, SOUTHERN AFRICA, CENTRAL AND EASTERN EUROPE
12 February 2020
We are proud to be able to help 22 million patients worldwide every year.
Founded in 1906, Norgine is a leading European specialist pharmaceutical company with a strong global network of partnerships.
This enables us to acquire, develop and commercialise innovative products that make a real difference to the lives of patients around the world.